LC
CLMT icon

Lindbrook Capital’s Calumet Specialty Products CLMT Stock Holding History

Lindbrook Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$16.5K Hold
1,300
– – ﹤0.01% 1439
2024
Q4 		$28.6K Hold
1,300
– – ﹤0.01% 1088
2024
Q3 		$23.2K Buy
+1,300
New +$20.8K ﹤0.01% 1214

Other funds holding CLMT

WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Lindbrook Capital's CLMT Position: Q1 2025 in Review

Lindbrook Capital held its Calumet Specialty Products (CLMT) position steady in Q1 2025 at 1,300 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

Lindbrook Capital first reported a position in CLMT in Q3 2024 and has held it in 3 quarters since. The position peaked at $28.6K in Q4 2024. 129 funds tracked by Wall St. Rank hold CLMT as of Q1 2025.

  • Lindbrook Capital held 1,300 shares of Calumet Specialty Products worth $16.5K as of Q1 2025.
  • Lindbrook Capital left its Calumet Specialty Products share count unchanged in Q1 2025.
  • Calumet Specialty Products made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1439 holding.
  • Lindbrook Capital first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 3 quarters since.
  • Lindbrook Capital's Calumet Specialty Products position peaked at $28.6K in Q4 2024.
  • 129 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.